Delivery Order SPE2DR25D2014-SPE2DR26FZ83J
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,573.26 on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price contract, issued by the Defense Logistics Agency's Medical Supply Chain division, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,028.55 on November 24, 2025, under a Defense Logistics Agency (DLA) contract. This firm fixed-price, competitively awarded delivery order with an ultimate completion date of November 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 on November 17, 2025, under a firm fixed-price contract. This non-set-aside delivery order is expected to be completed by November 18, 2025, and represents a child contract under the company's larger pharmaceutical supply agreement with the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. AmerisourceBergen...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $343,309.98 by the Defense Logistics Agency's Medical Supply Chain on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price contract is a non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $137,948.52 by the Defense Logistics Agency's Medical Supply Chain division. The competitively awarded, firm fixed-price contract has a completion date of November 28, 2025, and represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,830.36 by the Defense Logistics Agency's Medical Supply Chain on November 30, 2025. This firm fixed price delivery order, which is a child contract under a larger vehicle, is scheduled for completion by December 1, 2025, and represents a non-competitive set-aside award. The contract reflects AmerisourceBergen's ongoing role as a critical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $108,741.25 by the Defense Logistics Agency's Medical Supply Chain on November 5, 2025. The contract, designated as a child order under a larger indefinite delivery vehicle, utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by November 6, 2025. The award reflects the company's competitive standing within the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,514.52 on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, with an ultimate completion date of August 29, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,515.16 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $366,721.54 by the Defense Logistics Agency's Medical Supply Chain on December 8, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ83JDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for $4,066.16 to supply Nemluvio 30 mg pens. The contract, awarded on December 1, 2025, with an ultimate completion date of December 22, 2025, utilizes a firm fixed price structure with no set-aside designation. This delivery order represents a competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a vast range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The Defense Logistics Agency Medical Supply Chain relies on AmerisourceBergen as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order demonstrates the company's ongoing role in fulfilling specialized pharmaceutical needs across the federal government, including support for the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive portfolio of federal contract awards reflects its capability to meet competitive procurement requirements across multiple therapeutic domains, from specialty medications to brand-name and generic drugs, positioning the company as a key partner in the Department of Defense's medical supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 11/30/25 |